Former J&K Governor Satya Pal Malik hospitalised in Delhi, condition critical
Former Jammu and Kashmir Governor Satya Pal Malik's health is critical and he is hospitalised at the Dr Ram Manohar Lohia Hospital in Delhi. He is suffering from severe complications related to a urinary tract infection that has now led to kidney failure, sources told India Today TV.Malik was hospitalised on May 11 after he reportedly experienced extreme pain and difficulty in passing urine. A close aide of Satya Pal Malik has confirmed that both of his kidneys have now stopped functioning, and his condition remains extremely serious.advertisement"Initially, he was diagnosed with a urinary tract infection, but the infection has now severely damaged his kidneys," a senior doctor from RML Hospital stated on condition of anonymity. "We are doing everything we can, but the situation is very grave," sources said.
Earlier on Thursday, the CBI chargesheeted the former Rajya Sabha MP in connection with an alleged corruption case in which civil works contracts for the Kiru Hydroelectric Power Project, valued at approximately Rs 2,200 crore, were awarded.However, sources close to him have strongly denied his involvement in the case, calling the move politically motivated."We were the complainants in this case. Satyapal Malik has no involvement whatsoever," his close aide said. "This chargesheet appears to be an act of vendetta politics".Malik, who has previously served as the Governor of multiple states, including Jammu and Kashmir and Goa, has often been vocal on matters of public integrity and national interest.His deteriorating health has prompted reactions from several political and civil society leaders, who are keeping a close watch on both his medical and legal situations.Must Watch
IN THIS STORY#Jammu and Kashmir
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
2 hours ago
- Business Standard
Aayush Wellness Limited to Form Wholly Owned Subsidiary in Singapore to Drive Southeast Asia Expansion
VMPL New Delhi [India], June 10: Aayush Wellness Limited [BSE:539528], an integrated healthcare company dedicated to holistic wellness and innovation, is pleased to announce that its Board of Directors has approved the formation of a wholly owned subsidiary in Singapore with an initial capital investment of SGD 10,000. Highlights:- * Aayush Wellness Limited Stock Price at 52 week High of Rs. 151.05 per share * Income from Operations jump multifold to Rs. 73.34 crore in FY 2024-25 * Net Profit for FY 25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y * Company is planning expansion into preventive healthcare with Smart Health Kiosks & Medical Support centre; To Invest upto Rs. 25 crore in the expansion This strategic expansion marks a significant step in the company's global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets. Mr. Naveena Kumar, Managing Director of Aayush Wellness said, "Our new Singapore-based subsidiary will enable us to tap into one of the world's most dynamic wellness markets, offering greater agility in operations, regulatory efficiency, and direct access to high-growth ASEAN economies. This is a critical step toward building a global wellness brand." Unlocking Regional Potential: The Southeast Asian nutraceutical market is projected to reach USD 15.1 billion by 2028, growing at a CAGR of 7.5%, driven by rising health consciousness, urbanization, and preference for preventive healthcare solutions. Singapore, in particular, stands out as a key market and gateway for regional expansion. The country's nutraceutical sector is valued at over USD 1.3 billion, with steady growth driven by an aging population, high per capita health spending, and a consumer base that actively seeks functional foods, dietary supplements, and herbal wellness solutions. Its strong regulatory framework and international connectivity make it an ideal base for Aayush Wellness's global ambitions. Key Focus Areas of the Subsidiary: * Localizing product offerings to align with regulatory and cultural preferences. * Forging strategic partnerships and e-commerce distribution channels across ASEAN. * Driving export growth from India while expanding the company's international brand presence. * Establishing a regional R & D and innovation hub to adapt to market-specific wellness trends. Aligned with Aayush Wellness's Vision: This development is in line with Aayush Wellness Limited's broader mission to deliver science-backed, sustainable, and natural healthcare solutions globally. The company aims to use its new presence in Singapore to not only access markets in Malaysia, Indonesia, Thailand, and Vietnam, but also to establish a foundation for future global partnerships and innovation. For the Financial year 2024-25 ended 31st March 2025. company has reported income from operations of Rs. 73.34 crore for FY2024-25, multifold growth as compared to the income from operations of Rs. 60 lakh in the corresponding period last year. Net profit of the company for the FY 2024-25 was reported at Rs. 3.05 crore, 434% rise Y-o-Y as compared to the net profit of Rs. 57 lakh in the corresponding period in FY 2023-24. The stock price was up and touched 52 week high of Rs. 151.05 per share on 9 June 2025. The share price was in the buyer circuit for the last many days with good volumes. Aayush Wellness is also taking ambitious strides into offline preventive healthcare. Company has launched its first healthcare centre in Virar (Mumbai), Maharashtra. Inspired by the E Sanjeevani National Telemedicine Service of the Ministry of Health and Family Welfare, Aayush Wellness has installed a health ATM that shall conduct a wide range of diagnostics tests, in 2-3 minutes, maintain digital health records, and also facilitate Telemedicine to address health deficiencies before they become critical. The Company plans to invest up to Rs. 25 crores in the first phase and shall review further investments based on business requirements. This expansion will increase company's physical presence across geographies all over India, improve the offline distribution network for our products and provide complete preventive healthcare solutions under one roof. The Cloud Clinic model through this Health ATM is unique as it will deliver affordable yet high quality healthcare services to under privileged population of India. Solution offer by the company not only promotes early detection and prevention but also empowers individuals, especially those in rural and semi-urban areas, to take charge of their health in an accessible, cost-effective manner." The health ATM shall be able to conduct a up to 59 test including blood test, sugar test, Urine test, Haemoglobin test, skin test, eye test, cancer risk test, Lipid Profile test, and other basic health checkups, at a very affordable price. Further, the health ATM shall also facilitate Telemedicine, maintain Digital Health Records, Cloud connectivity generates smart reports and integration with Ayushman Bharat Digital Mission to benefit majority of the Indian Population About Aayush Wellness Limited: (ISO 9000 and 22000 certified company) Aayush Wellness Limited [BSE scrip code: 539528], established in 1989 is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation. We are India's preventive healthcare company committed to offer quality products and services to enhance the consumer well-being. Aayush Wellness continues to lead the industry in promoting healthier lifestyle choices through its diverse range of wellness products and services. For more information, please visit
Time of India
4 hours ago
- Time of India
Janitri raises $1.4 million pre-series A led by investor Ashish Kacholia
Bangalore-based Janitri , a maternal healthcare technology company, has raised $1.4 million in a pre-Series A round led by investor Ashish Kacholia , Founder, Lucky Investments Manager, who has doubled down on the company, having also participated in the previous round. Participants in this round included Prateek Maheshwari , Pradip Todi via O2 Angels, and the tal64 syndicate. While the current funding round is primarily based on Janitri's proven B2B success, a portion of the raised funds will be strategically allocated to enter the consumer segment. Kacholia said in a statement, 'Arun has spent time and effort in understanding unmet customer needs in the 1000-days journey of maternal care. Janitri's product is compact, full function, and enables cost-effective monitoring of mother and newborn for both hospital and home segment. It is a large market in India and overseas and hopefully, Janitri will identify more such market gaps to build a large and profitable medtech company out of India.' Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track default , selected Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villa For Sale in Dubai Might Surprise You Villas in Dubai | Search ads Learn More Undo Agarwal said in a statement, 'Janitri is building products focused on the 1000-day pregnancy journey of a mother and child. The goal is to bring joy to the mother, father, and the whole family as they anticipate and prepare for the arrival of their newborn into the world.' With this new funding, Janitri plans to expand its sales and support network across India; enhance its product suite with new offerings focused on in-home maternal healthcare; develop wearable vital signs patches for remote monitoring in the third trimester; create neonatal monitoring solutions for high-risk newborns and scale operations to reach Rs 3 crore monthly revenue in the next 12 months. Live Events The company's flagship product, Keyar, is an intrapartum monitoring device that tracks vital signs of pregnant women during labor, helping detect complications early and enabling timely interventions. Janitri addresses a critical gap in healthcare delivery — inadequate vital signs monitoring during labor, which contributes significantly to maternal and child mortality rates.
Time of India
5 hours ago
- Time of India
Health News: More Women Opting to Freeze Eggs Amid Health, Lifestyle, and Career Challenges
Declining quality of life due to lifestyle changes and environmental factors is not only impacting overall health but also affecting fertility, especially at a later age. Considering this, more women today are exploring the option of freezing their eggs for having a healthy baby in the future. Shiba Vyas, a 28 years old software engineer, recently froze her eggs. 'I want to become a mother but in the future and not now. However, I came across information that the quality of eggs lessens with time. And aspects like the modern lifestyle that is full of junk food, smoking, and drinking alcohol affect eggs quality negatively. Hence, I decided to freeze my eggs,' she said. Vyas is not alone. More and more women, mostly from metro cities and working women, prefer to freeze their eggs for various reasons. What is egg freezing? Dr Rajendra Shitole, Clinical and Academic Head, DPU IVF and Endoscopy Centre (DPU Super Specialty Hospital, Pimpri), said, 'Egg freezing, or oocyte cryopreservation, is a fertility preservation technique that allows women to store their eggs at a younger age for future use. With shifting priorities and evolving lifestyles, more women today are choosing to delay motherhood—for education, career, or medical reasons.' Dr Bushra Khan, fertility specialist, says, 'Egg freezing is done for two reasons: social and medical. Social is when younger women want to delay their pregnancies. For healthy eggs, they store it. And medical is when women have cancer or other diseases. Before taking chemotherapy, they freeze their eggs as chemotherapy affects negatively on eggs. Women with a family history of early menopause also go for it. We receive 7-10 queries per month and 7-8 women opt for it per month,' said Dr Khan. The perfect time to freeze eggs The best time to freeze eggs is before 35, when egg quality is highest. The process involves hormonal stimulation for 10–12 days, followed by egg retrieval under mild sedation with a sonography machine. The mature eggs are then vitrified and stored for ten years safely in liquid nitrogen. 'Success depends on age at freezing and the number of eggs stored. Egg survival after freezing is almost 90% due modern vitrification techniques. With eggs frozen before 35, the chances of a healthy pregnancy can be up to 40–60% per embryo transfer. Research shows no increased risk of birth defects or developmental issues in children born from frozen eggs,' says Dr Shitole. Myths busted 'There are many myths around egg freezing. It is said that egg freezing guarantees future pregnancy. However, in reality, it increases the chances, but success still depends on several factors. Another myth is the procedure is unsafe. But in reality, it is well-established and minimally invasive,' said Dr Khan. According to both experts, this is not a new technique and has been used in western world for a long time. But now it is becoming popular in India, especially in metro cities. It costs Rs 1.50 lakh to Rs 2.50 lakh and is affordable for many middle-class families. Need of the hour Priyanka Khade (name changed), 27 years old working woman, recently tested with breast cancer. 'I want to become a mother for sure. Doctors counselled me about why I needed to freeze my eggs. And I realised that chemotherapy might reduce my chances to become a mother as egg quality gets reduced due to therapy. Hence, I decided to freeze my eggs.'
